These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23996162)
1. Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis. Heger U; Bader F; Lordick F; Burian M; Langer R; Dobritz M; Blank S; Bruckner T; Becker K; Herrmann K; Siewert JR; Ott K Gastric Cancer; 2014; 17(3):478-88. PubMed ID: 23996162 [TBL] [Abstract][Full Text] [Related]
2. Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation. Blank S; Lordick F; Bader F; Burian M; Dobritz M; Grenacher L; Becker K; Weichert W; Langer R; Sisic L; Stange A; Jäger D; Büchler M; Bruckner T; Siewert J; Ott K Gastric Cancer; 2015 Apr; 18(2):314-25. PubMed ID: 24722800 [TBL] [Abstract][Full Text] [Related]
4. Evaluations of primary lesions by endoscopy clearly distinguishes prognosis in patients with gastric cancer who receive chemotherapy. Tahara T; Shibata T; Okubo M; Kawamura T; Horiguchi N; Yoshida D; Ishizuka T; Nagasaka M; Nakagawa Y; Ohmiya N PLoS One; 2017; 12(3):e0173663. PubMed ID: 28288188 [TBL] [Abstract][Full Text] [Related]
5. Endoscopic Evaluation of Neoadjuvant Chemotherapeutic Efficacy in Gastric Cancer before Gastrectomy Might be as Useful as Histological Assessment after Gastrectomy. Sugawara N; Ota K; Terazawa T; Tanaka R; Akutagawa H; Yamaguchi T; Imai Y; Harada S; Kojima Y; Tashiro K; Kii T; Lee SW; Kawai M; Egashira Y; Goto M; Uchiyama K; Hirose Y; Takeuchi T; Higuchi K Digestion; 2020; 101(4):466-472. PubMed ID: 31256160 [TBL] [Abstract][Full Text] [Related]
6. Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial. Lorenzen S; von Gall C; Stange A; Haag GM; Weitz J; Haberkorn U; Lordick F; Weichert W; Abel U; Debus J; Jäger D; Münter MW BMC Cancer; 2011 Jun; 11():266. PubMed ID: 21702914 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of Japan clinical oncology group study: JCOG1302A. Sato Y; Mizusawa J; Katayama H; Nakamura K; Fukagawa T; Katai H; Haruta S; Yamada M; Takagi M; Tamura S; Yoshimura T; Tokunaga M; Yoshikawa T; Boku N; Sano T; Sasako M; Terashima M Eur J Surg Oncol; 2020 Jun; 46(6):1074-1079. PubMed ID: 32173178 [TBL] [Abstract][Full Text] [Related]
8. [Accuracy comparision of abdominal enhanced CT and endoscopic ultrasound in the staging of gastric cancer after neoadjuvant chemotherapy: a post hoc analysis of a randomized clinical trial]. Wang YK; Shan F; Ying XJ; Zhang Y; Xiao QY; Tang L; Wu Q; Li ZY; Ji JF Zhonghua Wai Ke Za Zhi; 2020 Aug; 58(8):614-618. PubMed ID: 32727193 [No Abstract] [Full Text] [Related]
9. Contrast-enhanced ultrasonography assessment of gastric cancer response to neoadjuvant chemotherapy. Ang J; Hu L; Huang PT; Wu JX; Huang LN; Cao CH; Zheng YX; Chen L World J Gastroenterol; 2012 Dec; 18(47):7026-32. PubMed ID: 23323004 [TBL] [Abstract][Full Text] [Related]
10. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy. Liu K; Li G; Fan C; Zhou C; Li J Acta Radiol; 2012 Mar; 53(2):127-34. PubMed ID: 22156007 [TBL] [Abstract][Full Text] [Related]
11. Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor. Ott K; Blank S; Becker K; Langer R; Weichert W; Roth W; Sisic L; Stange A; Jäger D; Büchler M; Siewert JR; Lordick F Langenbecks Arch Surg; 2013 Feb; 398(2):239-49. PubMed ID: 23269519 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study. Yoshikawa T; Tanabe K; Nishikawa K; Ito Y; Matsui T; Kimura Y; Hasegawa S; Aoyama T; Hayashi T; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S385-9. PubMed ID: 24595801 [TBL] [Abstract][Full Text] [Related]
13. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039 [TBL] [Abstract][Full Text] [Related]
14. [18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. Vallböhmer D; Hölscher AH; Schneider PM; Schmidt M; Dietlein M; Bollschweiler E; Baldus S; Alakus H; Brabender J; Metzger R; Mönig SP J Surg Oncol; 2010 Aug; 102(2):135-40. PubMed ID: 20648583 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and multiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology. Bhandari S; Shim CS; Kim JH; Jung IS; Cho JY; Lee JS; Lee MS; Kim BS Gastrointest Endosc; 2004 May; 59(6):619-26. PubMed ID: 15114303 [TBL] [Abstract][Full Text] [Related]
16. Sequential endoscopic ultrasound identifies predictive variables for relapse-free follow-up after neoadjuvant chemotherapy in gastric cancer. Bohle W; Zachmann R; Zoller WG Scand J Gastroenterol; 2017; 52(6-7):754-761. PubMed ID: 28355948 [TBL] [Abstract][Full Text] [Related]
17. Complete Metabolic Response on Interim Chen S; Ibrahim NK; Yan Y; Wong ST; Wang H; Wong FC Oncologist; 2017 May; 22(5):526-534. PubMed ID: 28377466 [TBL] [Abstract][Full Text] [Related]
18. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker. Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051 [TBL] [Abstract][Full Text] [Related]
19. [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Vallböhmer D; Hölscher AH; Dietlein M; Bollschweiler E; Baldus SE; Mönig SP; Metzger R; Schicha H; Schmidt M Ann Surg; 2009 Dec; 250(6):888-94. PubMed ID: 19953708 [TBL] [Abstract][Full Text] [Related]
20. Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer. Hulikal N; Gajjala SR; Kalawat T; Kadiyala S; Kottu R Asian Pac J Cancer Prev; 2020 Jan; 21(1):93-98. PubMed ID: 31983170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]